666

HEILONGJIANG ZBD PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪10.29 B‬CNY
‪185.39 M‬CNY
‪4.17 B‬CNY
‪207.62 M‬
Beta (1Y)
1.48

About HEILONGJIANG ZBD PHARMACEUTICAL

CEO
Jiu Liang Yan
Headquarters
Harbin
Website
Employees (FY)
‪2.76 K‬
Founded
1996
ISIN
CNE100002219
FIGI
BBG006FTGV46
HeiLongJiang ZBD Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine. It also engages in the trading of drug and Chinese herbal medicine. The company business areas include Industrial and Commercial. Its products include Chinese medicine preparations, biological agents, and chemical agents. The company was founded by Tong Hua Fang on October 28, 1996 and is headquartered in Harbin, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 603567 is 11.24 CNY — it has increased by 2.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HEILONGJIANG ZBD PHARMACEUTICAL stocks are traded under the ticker 603567.
603567 stock is 3.77% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is HEILONGJIANG ZBD PHARMACEUTICAL there?
Yes, you can track HEILONGJIANG ZBD PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
603567 stock has risen by 3.40% compared to the previous week, the month change is a 0.71% fall, over the last year HEILONGJIANG ZBD PHARMACEUTICAL has showed a 28.77% decrease.
603567 net income for the last quarter is ‪131.92 M‬ CNY, while the quarter before that showed ‪89.85 M‬ CNY of net income which accounts for 46.82% change. Track more HEILONGJIANG ZBD PHARMACEUTICAL financial stats to get the full picture.
Today HEILONGJIANG ZBD PHARMACEUTICAL has the market capitalization of ‪10.29 B‬, it has increased by 0.63% over the last week.
Yes, 603567 dividends are paid annually. The last dividend per share was 0.03 CNY. As of today, Dividend Yield (TTM)% is 0.26%. Tracking HEILONGJIANG ZBD PHARMACEUTICAL dividends might help you take more informed decisions.
HEILONGJIANG ZBD PHARMACEUTICAL dividend yield was 0.22% in 2022, and payout ratio reached 14.22%. The year before the numbers were 0.69% and 27.60% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603567 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEILONGJIANG ZBD PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
603567 reached its all-time high on May 28, 2015 with the price of 60.16 CNY, and its all-time low was 8.89 CNY and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪2.76 K‬ employees. See our rating of the largest employees — is HEILONGJIANG ZBD PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEILONGJIANG ZBD PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEILONGJIANG ZBD PHARMACEUTICAL stock shows the sell signal. See more of HEILONGJIANG ZBD PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.